Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Industrial

Thyssenkrupp’s Historic Pivot: Defense Boom and Steel Restructuring Reshape Industrial Giant

Robert Sasse by Robert Sasse
October 6, 2025
in Industrial, IPOs, Turnaround
0
Thyssenkrupp Stock
0
SHARES
32
VIEWS
Share on FacebookShare on Twitter

The historic German industrial conglomerate Thyssenkrupp is navigating its most significant transformation in modern history. This dramatic overhaul presents a tale of two diverging business units: while its naval division TKMS prepares for a multi-billion euro market debut, the company’s traditional steel operations face severe contraction with thousands of job cuts and production capacity reductions. Complicating this balancing act, billionaire investor Daniel Kretinsky has unexpectedly exited the steel joint venture, potentially clearing the path for new partnership opportunities with Indian steel producers.

Naval Division TKMS Sets Course for October IPO

Market attention is focused on October 20, when Thyssenkrupp plans to list its marine systems subsidiary TKMS. Financial experts project a valuation between €2.3 and €2.7 billion for the naval defense unit, representing approximately one-third of the entire corporation’s market capitalization.

The strategic maneuver allows Thyssenkrupp to maintain majority control with a 51% stake while generating substantial proceeds from selling the remaining 49% to public market investors. TKMS has capitalized significantly on Europe’s defense spending surge, with its order backlog expanding dramatically to €18.6 billion over five years—more than triple previous levels.

TKMS Financial Highlights:
– Target operating margin exceeding 7% (compared to 4.3% in 2023/24)
– Projected annual revenue growth of 10%
– Current order backlog: €18.6 billion
– Anticipated IPO valuation reaching €2.7 billion

Steel Division Restructuring Accelerates Amid Investor Exit

As TKMS thrives, Thyssenkrupp’s steel operations face substantial downsizing. Internal restructuring documents outline plans to reduce production capacity from 11.5 million tons to between 8.7 and 9.0 million tons. The consolidation will eliminate 5,000 positions by 2030, with an additional 6,000 jobs slated for transfer or sale to external entities.

In a surprising development, Czech billionaire Daniel Kretinsky’s EP Group has withdrawn from its 20% stake in the steel division, acquired just last year. This reversal terminates negotiations for a proposed 50:50 joint venture, dealing a significant setback to CEO Miguel López Borrego’s strategic plans.

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

Paradoxically, Kretinsky’s departure may create opportunity. Indian steel producer Jindal Steel has emerged as a potential new partner, expressing interest in acquiring a stake in Thyssenkrupp’s steel operations.

Hydrogen Transition Strategy Maintains Forward Momentum

Despite substantial cuts to its conventional steel operations, Thyssenkrupp remains committed to its green transformation strategy. The company plans to commission a direct reduction plant in Duisburg by 2027, initially operating on natural gas before transitioning to green hydrogen.

The initiative has already secured a significant endorsement, with Volkswagen signing a letter of intent to purchase CO₂-reduced “bluemint® Steel” beginning in 2028. This early commitment could encourage other automotive manufacturers to follow suit.

Share Performance Reflects Transformation Optimism

Thyssenkrupp’s equity has responded dramatically to these strategic shifts, skyrocketing 275% over the past twelve months. Shares recently reached a 52-week peak of €12.40, indicating strong market confidence in the corporate overhaul.

Technical indicators suggest the stock may be overbought in the near term, with the Relative Strength Index registering at 17.5. However, traditional valuation metrics may prove less relevant during such a fundamental corporate transformation of historic proportions.

Ad

Thyssenkrupp Stock: Buy or Sell?! New Thyssenkrupp Analysis from March 25 delivers the answer:

The latest Thyssenkrupp figures speak for themselves: Urgent action needed for Thyssenkrupp investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Thyssenkrupp: Buy or sell? Read more here...

Tags: Thyssenkrupp
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Hain Celestial Stock
Analysis

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Lumen Stock
AI & Quantum Computing

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

March 25, 2026
Watsco Stock
Analysis

Watsco’s Dividend Hike Contrasts with Operational Headwinds

March 25, 2026
Next Post
Nordstrom Stock

Nordstrom's Market Exit Marks New Chapter Under Private Ownership

Consumer Portfolio Services Stock

Subprime Auto Lender CPSS Sees Sharp Single-Day Rally Amid Longer-Term Decline

Plus Therapeutics Stock

Plus Therapeutics Shares Surge on Analyst Upgrade and Insider Buying

Recommended

Oracle Stock

Oracle Shares Face Sector-Wide Pressure Despite Solid Long-Term Chart

7 months ago
Telecommunications Industry stock Trading

Globalstar Forecasts Strong Financial Performance and Growth Initiatives for 2024

2 years ago
Pulmonx Corp Stock

Pulmonx Shares Surge on Leadership Shakeup and Upbeat Forecast

5 months ago
Healthcare-sector

Analysts Divided on GE HealthCare Technologies Evaluating the Potential of the Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hain Celestial Sheds Snack Division in Strategic Overhaul

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

Lumen’s AI Infrastructure Push Gains Recognition Amid Strategic Overhaul

Microsoft’s AI Ambitions Strain Finances as Cash Reserves Shrink

Hesai Group’s Milestone Profit Tempered by Cautious Guidance

PagerDuty Charts a New Course with Autonomous AI Systems

Trending

Evolent Health Stock
AI & Quantum Computing

Evolent Health Bets on AI Leadership Amid Share Price Decline

by Jackson Burston
March 25, 2026
0

The healthcare technology company Evolent Health is making a strategic push into artificial intelligence, appointing a seasoned...

MongoDB Stock

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

March 25, 2026
Talphera Stock

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

March 25, 2026
Hain Celestial Stock

Hain Celestial Sheds Snack Division in Strategic Overhaul

March 25, 2026
Technology Select Sector SPDR® Fund Stock

Technology Sector Faces Mounting Headwinds as AI Hype Meets Macroeconomic Reality

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Evolent Health Bets on AI Leadership Amid Share Price Decline
  • MongoDB Strengthens Leadership Amid AI-Driven Growth Phase
  • Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com